These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 478046)

  • 1. Colchicine therapy in scleroderma. Preliminary results.
    Frayha RA
    Dermatologica; 1979; 159(1):78-81. PubMed ID: 478046
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term evaluation of colchicine in the treatment of scleroderma.
    Alarcon-Segovia D; Ramos-Niembro F; Ibanez de Kasep G; Alcocer J; Tamayo RP
    J Rheumatol; 1979; 6(6):705-12. PubMed ID: 529256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scleroderma in the child. Treatment with colchicine].
    Harpey JP; Renault F; Roy C; Lafourcade J
    Nouv Presse Med; 1980 Oct; 9(38):2844. PubMed ID: 7443410
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine in the treatment of scleroderma.
    Guttadauria M; Diamond H; Kaplan D
    J Rheumatol; 1977; 4(3):272-6. PubMed ID: 926103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of colchicine in progressive systemic sclerosis].
    Tanimoto K; Oohama Y; Yamada A; Moroi Y; Matsuo H
    Ryumachi; 1977 Jan; 17(1):56-62. PubMed ID: 847544
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Treatment of scleroderma.
    Alarcón-Segovia D; Ibáñez G; Kershenobich D; Rojkind M
    Lancet; 1974 May; 1(7865):1054-5. PubMed ID: 4133735
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Skin elasticity and colchicine in scleroderma.
    Fernandez-Herlihy L
    Arthritis Rheum; 1976; 19(4):832-3. PubMed ID: 942510
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of certain colchicine derivatives in the treatment of sclerodermic syndromes].
    Housset E
    Ann Dermatol Syphiligr (Paris); 1967; 94(1):31-4. PubMed ID: 6059735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immediate results of long-term treatment of systemic scleroderma with leukeran].
    Olszewska Z
    Reumatologia; 1978; 16(2):259-66. PubMed ID: 358343
    [No Abstract]   [Full Text] [Related]  

  • 10. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis.
    Fuchs D; Fruchter L; Fishel B; Holtzman M; Yaron M
    Clin Rheumatol; 1986 Dec; 5(4):527-30. PubMed ID: 3816102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic anemia during cyclofenil treatment of scleroderma.
    Wollheim FA; Ljunggren HO; Blom-Bülow B
    Acta Med Scand; 1981; 210(5):429-30. PubMed ID: 7039243
    [No Abstract]   [Full Text] [Related]  

  • 12. [Scleroderma in childhood].
    Becerril-Sánchez JF; Roldán-Labrada ME
    Bol Med Hosp Infant Mex; 1984 Oct; 41(10):556-60. PubMed ID: 6508897
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some newer biological properties of colchicine and its derivatives].
    Trnavský K; Trnavská Z; Mikulíková D
    Cas Lek Cesk; 1977 May; 116(18):564-7. PubMed ID: 880594
    [No Abstract]   [Full Text] [Related]  

  • 14. Colchicine for dermatologic diseases.
    Bibas R; Gaspar NK; Ramos-e-Silva M
    J Drugs Dermatol; 2005; 4(2):196-204. PubMed ID: 15776777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of systemic scleroderma].
    Priollet P; Baudot N; Fiessinger JN; Vayssairat M; Housset E
    Ann Dermatol Venereol; 1984; 111(6-7):595-607. PubMed ID: 6388467
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apropos of 37 cases of scleroderma].
    Huriez C; Agache P; Gauthier G
    Arch Belg Dermatol Syphiligr; 1967; 23(1):3-8. PubMed ID: 5619145
    [No Abstract]   [Full Text] [Related]  

  • 17. A double blind study of colchicine in Behçet's disease.
    Aktulga E; Altaç M; Müftüoglu A; Ozyazgan Y; Pazarli H; Tüzün Y; Yalçin B; Yazici H; Yurdakul S
    Haematologica; 1980 Jun; 65(3):399-402. PubMed ID: 6778795
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclofenil treatment of scleroderma--a controlled study.
    Gibson T; Grahame R
    Br J Rheumatol; 1983 Nov; 22(4):218-23. PubMed ID: 6360282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine: effects upon urinary hydroxyproline excretion in patients with scleroderma.
    Harris ED; Hoffman GS; McGuire JL; Strosberg JM
    Metabolism; 1975 Apr; 24(4):529-35. PubMed ID: 1117843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma: therapeutic options.
    Connolly SM
    Cutis; 1984 Sep; 34(3):274-6. PubMed ID: 6386354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.